| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8674626 | Nutrition, Metabolism and Cardiovascular Diseases | 2017 | 22 Pages |
Abstract
Treatment with GLP-1 agonists in DM patients is associated with a significant reduction of all cause and CV mortality.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
P. Gargiulo, G. Savarese, C. D'Amore, F. De Martino, L.H. Lund, F. Marsico, S. Dellegrottaglie, C. Marciano, B. Trimarco, P. Perrone-Filardi,